We reported the presence of potentially pathogenic variants that could explain the familial predisposition to Lynch syndrome-related tumors without a germline basis of MMR deficiency, including cases with MLH1 methylation, which could support new screening strategies for the identification of families at risk of developing cancer. Here, MLH1 is linked to mismatch repair cancer syndrome 1.